Dr Reddy's & Torrent Pharma Sign Agreement for Exclusive Commercialization of Listril And Listril Plus in Russia

Dr Reddys Laboratories Ltd has announced that the Company and Torrent Pharmaceuticals Ltd on November 29, 2006 have announced that they have concluded an agreement for exclusive commercialization of two of Torrent's brands in Russia, viz. Listril (Lisinopril) and Listril Plus (Lisinopril HCTZ), both of which are cardiovascular drugs used in the treatment of high blood pressure. The two brands would add to the stable of cardiovascular drugs the Company is currently offering in Russia. This agreement offers the potential for immediate commercialization of these two brands as they have already been registered in Russia.

This is the second agreement of this kind that the Company has made with Torrent Pharma for the territory of Russia. The first was related to the licensing for Omez D (Omeprazole 10mg + Domperidone 10 mg, used to treat gastro-intestinal diseases like heartburn, dyspepsia and epigastric pain), a product that will be launched in Ukraine and Kazakhstan in the short term, followed by Russia and Belarus.

Source : Equity Bulls

Keywords